Literature DB >> 14354848

[Controlled hypotension and renal function].

J MOELLER, A WEDL.   

Abstract

Entities:  

Keywords:  HYPOTENSION; KIDNEY FUNCTION TESTS

Mesh:

Year:  1955        PMID: 14354848     DOI: 10.1007/bf01466916

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


× No keyword cloud information.
  20 in total

1.  [Orthostatic variations of phenol red excretion, and circulatory volume in sitting with and without collapse phenomena].

Authors:  F PARR; K J ULLRICH
Journal:  Z Klin Med       Date:  1954

2.  [Cardiac catheterization studies in severe hexamethonium-induced hypotension].

Authors:  H VETTER; G GRABNER; F MLCZOCH; K STEINBEREITHNER
Journal:  Klin Wochenschr       Date:  1954-02-01

3.  [Behavior of renal function after controlled hypotension].

Authors:  F HOLLE; E KERN
Journal:  Klin Wochenschr       Date:  1954-01-15

4.  Hexamethonium-its effect on glomerular filtration rate, maximal tubular function and renal excretion of electrolytes.

Authors:  J H MOYER; L C MILLS
Journal:  J Clin Invest       Date:  1953-02       Impact factor: 14.808

5.  [Experiences and remarks to the controlled fall of blood pressure in pulmonary surgery].

Authors:  Y SAUVAGE; T HOFFMANN
Journal:  Med Klin       Date:  1952-11-14

6.  Hexamethonium compounds in the treatment of hypertension.

Authors:  J D BLAINEY
Journal:  Lancet       Date:  1952-05-17       Impact factor: 79.321

7.  [Peroperative hemostasis with hexamethonium and the patient in inclined position].

Authors:  T HOFFMANN
Journal:  Munch Med Wochenschr       Date:  1952-04-11

8.  Excretion of the methonium compounds.

Authors:  G E MILNE; S OLEESKY
Journal:  Lancet       Date:  1951-04-21       Impact factor: 79.321

9.  [On the most important non-renal diseases due to disorders of tubular resorption. II].

Authors:  E FRANK
Journal:  Med Welt       Date:  1951-04-07

10.  Effect of hypotension producing drugs on the renal circulation.

Authors:  J MACKINNON
Journal:  Lancet       Date:  1952-07-05       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.